SGLT2 inhibitors and outcomes after surgical aortic valve replacement: attention to detail
Open Access
- 9 May 2026
- journal article
- letter
- Published by Springer Nature in The Cardiothoracic Surgeon
- Vol. 34 (1) , 21
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Initiation of peri-operative SGLT2 inhibitor reduces mortality and cardiovascular events after surgical aortic valve replacementThe Cardiothoracic Surgeon, 2026
- Association between Changes in Preoperative Serum Creatinine and Acute Kidney Injury after Cardiac Surgery: A Retrospective Cohort StudyKidney and Blood Pressure Research, 2024
- Atrial Fibrillation and Perioperative Inflammation (FIBRILLAMMED Study): A Retrospective Analysis of the Predictive Role of Preoperative Albumin-Adjusted Platelet-Leukocytic Indices in OPCABGTurkish Journal of Anaesthesiology and Reanimation, 2023
- Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 InhibitionCurrent Hypertension Reports, 2022
- Effect of diastolic dysfunction on postoperative outcomes after cardiovascular surgery: A systematic review and meta-analysisThe Journal of Thoracic and Cardiovascular Surgery, 2016